letter · Pediatric Rheumatology · 2022
Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata
Shengyan Liu, Xia Wu, Yihan Cao, Zhaohui Li, Yuchen Liu, Mingwei Ma, Chen Li
Cited by 2Open access
Abstract
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare chronic inflammatory disease with osteoarticular and cutaneous involvements as its main manifestations. Acne conglobata as a severe acne form may affect adolescent patients. Tumor necrosis factor inhibitors are usually used as a second-line therapy for refractory SAPHO syndrome and has been reported to treat acne conglobata successfully. We herein report three cases of adolescent patients with SAPHO syndrome associated with acne conglobata who were successfully treated with TNFi therapy.
Cite this paper
Liu, S., Wu, X., Cao, Y., Li, Z., Liu, Y., Ma, M., & Li, C. (2022). Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata. Pediatric Rheumatology, 20(1), 88. https://doi.org/10.1186/s12969-022-00749-9
Liu, Shengyan, et al. “Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata.” Pediatric Rheumatology, vol. 20, no. 1, 2022, p. 88, https://doi.org/10.1186/s12969-022-00749-9.
Liu, Shengyan, Xia Wu, Yihan Cao, Zhaohui Li, Yuchen Liu, Mingwei Ma, and Chen Li. 2022. “Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata.” Pediatric Rheumatology 20 (1): 88. https://doi.org/10.1186/s12969-022-00749-9.
Liu, S. et al. (2022) ‘Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata’, Pediatric Rheumatology, 20(1), p. 88. Available at: https://doi.org/10.1186/s12969-022-00749-9.
@article{liu2022tumor,
title = {{Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata}},
author = {Liu, Shengyan and Wu, Xia and Cao, Yihan and Li, Zhaohui and Liu, Yuchen and Ma, Mingwei and Li, Chen},
journal = {Pediatric Rheumatology},
volume = {20},
number = {1},
pages = {88},
year = {2022},
doi = {10.1186/s12969-022-00749-9}
}Made from the index record. Check names, capitalisation and page numbers against the paper. Need another style? AI for Research has over 10,000.
Related papers
The Influence of Modulating Substances on Tumor Necrosis Factor and Interleukin-6 Levels After Injection of Murine Tumor Necrosis Factor or Lipopolysaccharide in Mice
Claude Libert, Sigrid Van Bladel, Peter Brouckaert et al. · Journal of Immunotherapy · 1991
Cited by 32
Neonatal interleukin-1β (IL1β) and tumor necrosis factor-α (TNF): Circulating levels and cellular production
L.C. Miller · Cytokine · 1989
Cited by 0
Effect of OK-432 on production of interleukin 1 and tumor necrosis factor by mouse Kupffer cells.
Norifumi Kawada, Itaru HASEGAWA, Yuzo ICHIKAWA et al. · Kanzo · 1990
Cited by 0Open access
Requirement for the continual presence of lipopolysaccharide for production of tumor necrosis factor by thioglycollate‐induced peritoneal murine macrophages
George E. Gifford, Marie‐Luise Lohmann‐Matthes · International Journal of Cancer · 1986
Cited by 52
Tissue heterogeneity in the production of tumor necrosis factor (TNF) by rat macrophages
D.L. Laskin · Cytokine · 1989
Cited by 0
Effect of tumor necrosis factor-α on the nitric oxide level in cultured osteoblasts in vitro
H Ji · Journal of Bengbu Medical College · 2013
Cited by 0
Effects of tumor necrosis factor (TNF) and immunotherapy directed against TNF on rat cardiac transplants.
Philip Seu, David K. Imagawa, Olthoff Km et al. · PubMed · 1991
Cited by 1
Silica Increases Tumor Necrosis Factor (TNF) Production, in Part, by Upregulating the TNF Promoter
Dana Savici, Bei He, Lois J. Geist et al. · Experimental Lung Research · 1994
Cited by 34